Details of the Drug Formulations

General Information of Drug (ID: DMSI5CB)

Drug Name
Chloroquine Drug Info
Synonyms
Amokin; Aralen; Aralen HCl; Arechin; Arechine; Arequin; Arolen; Arthrochin; Artrichin; Avlochlor; Avloclor; Bemaco; Bemaphate; Bemasulph; Benaquin; Bipiquin; CU-01000012392-2; Capquin; Chemochin; Chingamin; Chloraquine; Chlorochin; Chlorochine; Chlorochinum; Chloroin; Chloroquin; Chloroquina; Chloroquine (USP/INN); Chloroquine (VAN); Chloroquine Bis-Phosphoric Acid; Chloroquine FNA (TN); Chloroquine [USAN:INN:BAN]; Chloroquine phosphate; Chloroquinium; Chloroquinum; Chloroquinum [INN-Latin]; Chlorquin; Cidanchin; Clorochina; Clorochina [DCIT]; Cloroquina; Cloroquina [INN-Spanish]; Cocartrit; Dawaquin (TN); Delagil; Dichinalex; Elestol; Gontochin; Gontochin phosphate; Heliopar; Imagon; Ipsen 225; Iroquine; Khingamin; Klorokin; Lapaquin; Malaquin; Malaquin (*Diphosphate*); Malaren; Malarex; Mesylith; Miniquine; Neochin; Nivachine; Nivaquine B; Pfizerquine; Quinachlor; Quinagamin; Quinagamine; Quinercyl; Quingamine; Quinilon; Quinoscan; RP 3377; RP-3377; Resochen; Resochin; Resochin (TN); Resoquina; Resoquine; Reumachlor; Reumaquin; Rivoquine; Ro 01-6014/N2; Ronaquine; Roquine; SN 6718; SN-7618; ST 21; ST 21 (pharmaceutical); Sanoquin; Silbesan;Siragan; Solprina; Sopaquin; Tanakan; Tanakene; Tresochin; Trochin; W 7618;WIN 244
Indication
Disease Entry ICD 11 Status REF
Malaria 1F40-1F45 Approved [1]
Plasmodium falciparum malaria 1F40 Approved [2]
Plasmodium malariae malaria Approved [2]
Plasmodium ovale malaria Approved [2]
Systemic lupus erythematosus 4A40.0 Approved [2]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 3 [3]
Middle East Respiratory Syndrome (MERS) 1D64 Investigative [4]
Severe acute respiratory syndrome (SARS) 1D65 Investigative [5]
Therapeutic Class
Antimalarials
Cross-matching ID
PubChem CID
2719
ChEBI ID
CHEBI:3638
CAS Number
54-05-7
TTD ID
D09EGZ
VARIDT ID
DR00572
INTEDE ID
DR0301
ACDINA ID
D00121

Full List of Drug Formulations Containing This Drug

Chloroquine 500 mg tablet
Company Formulation ID FDA Description
West-Ward Pharmaceticals F04006 Lactose monohydrate; D&c yellow no. 10; D&c red no. 27; Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Hypromellose; Polysorbate 80; Povidone k30; Cellulose, microcrystalline; Colloidal silicon dioxide; Polyethylene glycol; Sodium starch glycolate type a potato; Starch, corn
PD-Rx Pharmaceuticals F04009 Lactose monohydrate; D&c yellow no. 10; D&c red no. 27; Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Polysorbate 80; Povidone k30; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycol; Sodium starch glycolate type a potato; Starch, corn
Carilion Materials Management F04010 Lactose monohydrate; D&c yellow no. 10; D&c red no. 27; Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Polysorbate 80; Povidone k30; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Sodium starch glycolate type a potato; Starch, corn
Global Pharmaceuticals F04005 Anhydrous citric acid; Lactose monohydrate; Magnesium stearate; Cellulose, microcrystalline; Starch, corn; Starch, potato
Bryant Ranch Prepack F04011 Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 3350; Polyethylene glycol 400; Polysorbate 80; Silicon dioxide; Cellulose, microcrystalline; Povidones; Sodium starch glycolate type a potato; Starch, corn
PD-Rx Pharmaceuticals; Ranbaxy Pharmaceuticals F04012 Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 3350; Polyethylene glycol 400; Polysorbate 80; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Povidones; Sodium starch glycolate type a potato; Starch, corn
Rising Pharmaceuticals F04007 Magnesium stearate; Anhydrous dibasic calcium phosphate; Titanium dioxide; Polysorbate 80; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycol; Sodium starch glycolate type a potato; Starch, corn
A-S Medication Solutions F04008 Lactose monohydrate; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Povidones; Starch, corn
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Formulation(s)
Chloroquine 250 mg tablet
Company Formulation ID FDA Description
Global Pharmaceuticals F04001 Anhydrous citric acid; Lactose monohydrate; Magnesium stearate; Cellulose, microcrystalline; Starch, corn; Starch, potato
Bryant Ranch Prepack; Ranbaxy Pharmaceuticals F04004 Magnesium stearate; Talc; Titanium dioxide; Polyethylene glycol 3350; Polyethylene glycol 400; Polysorbate 80; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Povidones; Sodium starch glycolate type a potato; Starch, corn
Rising Pharmaceuticals F04003 Magnesium stearate; Anhydrous dibasic calcium phosphate; Cellulose, microcrystalline; Colloidal silicon dioxide; Sodium starch glycolate type a potato; Starch, corn
West-Ward Pharmaceticals F04002 Calcium stearate; Anhydrous dibasic calcium phosphate; Talc; Cellulose, microcrystalline; Colloidal silicon dioxide
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5535).
2 Chloroquine FDA Label
3 ClinicalTrials.gov (NCT04360759) Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19. U.S. National Institutes of Health.
4 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.
5 Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020 Mar;19(3):149-150.